News Releases

email   print   rss   

RSS Feeds

Quest Diagnostics To Speak At The 36th Annual J.P. Morgan Healthcare Conference

SECAUCUS, N.J., Jan. 3, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco. Steve Rusckowski, Chairman, President and CEO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence.  The presentation is scheduled for Wednesday, January 10, 2018 at 12:00 p.m. Eastern Time. At 12:30 p.m. Eastern Time, Mr. Rusckowski will be joined by Mark Guinan, Executive Vice President and CFO, in a Q&A session to be moderated by the host analyst.

Quest Diagnostics Incorporated logo. (PRNewsFoto/Quest Diagnostics Incorporated)

The presentation and Q&A session will be webcast live during the conference and will be available on the company's investor relations page which can be accessed at  In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until February 9, 2018. 

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes.  Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.


SOURCE Quest Diagnostics

For further information: Shawn Bevec (Investors): 973-520-2900; Dennis Moynihan (Media): 973-520-2800